Recent studies have shown that approximately 20% of adults in Europe inc1uded in Poland and in the United States have metabolic syndrome, a loosely defined of cardiovascular risk factor, inc1uding abdominal obesity, hypertension, prediadetes (impaired fasting plasma glucose, FPG (impaired glucose tolerance, IGT) or type 2 diabetes, hypertriglyceridemia, low levels of high-density lipoprotein cholesterol (HDL-C), and insulin resistance. With this syndrome looming as one of the most prevalent diseases of manking (as well as one of the most preventable), it is imperative that practitioners have a through understanding of this condition so that they can effectively diagnose and appropriately manage it in their practices. Current opinions on the treatment of metabolic syndrome are shown.